Pan-RAS inhibitor daraxonrasib doubles survival in pancreatic cancer trial
A new review details how the pan-RAS inhibitor daraxonrasib doubled overall survival in a phase III pancreatic cancer trial and ...
Tag: immunotherapy combinations
POPULAR NEWS
-
Global Financing Facility falls short on adolescent health funding in three country case studies
-
Prostate Cancer Detection Rose After MRI Arrived, But a Single-Centre Study Says the Reason Stays Unclear
-
Midday Sunlight Yields Smaller Copper Nanoparticles With Stronger Antibacterial Activity
-
Never-Smoker COPD Shows Stronger Lung Function Gains from Salbutamol and Glycopyrronium